With the aim of providing an overview of CAR-T cell treatment in myeloma, healthcare professional expectations and an introduction to some of the advantages and challenges for patients and in bringing it to market, Myeloma Patients Europe (MPE) will held a webinar on Thursday 9 May from 18:00 to 19:00 CET.
The webinar will be given by Dr Sara Mastaglio, Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan (Italy).
The webinar will last around 60-minutes, including a 40-minutes presentation by Dr Mastaglio followed by a 20-minute Q&A session. The target audience is patient advocates, patients and caregivers but anyone with an interest in the topic is more than welcome to attend.
Registration is free of charge. Please feel free to forward the registration link to colleagues who might be interested in attending the webinar.
Should you be unable to attend the webinar, please feel free to send your questions in advance to info@mpeurope.org who will make sure they reach the speaker.
A recording of the webinar will be available shortly after the session.
Register here!
Myeloma Patients Europe webinar on CAR-T cell treatment
